Cellosaurus SKM-1 (CVCL_0098)

Cell line name SKM-1
Synonyms SKM1
Accession CVCL_0098
Resource Identification Initiative To cite this cell line use: SKM-1 (RRID:CVCL_0098)
Comments Part of: Cancer Cell Line Encyclopedia (CCLE) project.
Part of: COSMIC cell lines project.
Doubling time: ~48 hours (PubMed=8136267); ~48 hours (DSMZ).
Microsatellite instability: Stable (MSS) (Sanger).
Omics: Deep exome analysis.
Omics: Deep RNAseq analysis.
Omics: DNA methylation analysis.
Omics: SNP array analysis.
Omics: Transcriptome analysis.
Derived from sampling site: Peripheral blood.
Sequence variations TP53 p.Tyr327His (PubMed=8136267).
Disease Adult acute myeloid leukemia (NCIt: C9154)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_IM24 (SKM-1/HHT)
Sex of cell Male
Age at sampling 76Y
Category Cancer cell line
STR profile Source(s): Cosmic-CLP; DSMZ; JCRB; PubMed=25877200

Markers:
AmelogeninX (Cosmic-CLP; JCRB)
X,Y (DSMZ; PubMed=25877200)
CSF1PO10,12
D13S31711,13
D16S5399,11
D18S5114,15
D21S1131.2,32.2
D3S135818
D5S81810,12
D7S82010,11
D8S117911,13
FGA22,23
Penta D9,12
Penta E15,20
TH017,9
TPOX8,11
vWA18
Publications

DOI=10.1007/978-1-4757-1647-4_13
Biedler J.L.
Chromosome abnormalities in human tumor cells in culture.
(In) Human tumor cells in vitro; Fogh J. (eds.); pp.359-394; Springer; New York (1975)

PubMed=8136267; DOI=10.1111/j.1365-2141.1993.tb03334.x
Nakagawa T., Matozaki S., Murayama T., Nishimura R., Tsutsumi M., Kawaguchi R., Yokoyama Y., Hikiji K., Isobe T., Chihara K.
Establishment of a leukaemic cell line from a patient with acquisition of chromosomal abnormalities during disease progression in myelodysplastic syndrome.
Br. J. Haematol. 85:469-476(1993)

PubMed=8580805; DOI=10.3109/10428199509056841
Nakagawa T., Matozaki S.
The SKM-1 leukemic cell line established from a patient with progression to myelomonocytic leukemia in myelodysplastic syndrome (MDS)-contribution to better understanding of MDS.
Leuk. Lymphoma 17:335-339(1995)

PubMed=16408098; DOI=10.1038/sj.leu.2404081
Quentmeier H., MacLeod R.A.F., Zaborski M., Drexler H.G.
JAK2 V617F tyrosine kinase mutation in cell lines derived from myeloproliferative disorders.
Leukemia 20:471-476(2006)

PubMed=22460905; DOI=10.1038/nature11003
Barretina J.G., Caponigro G., Stransky N., Venkatesan K., Margolin A.A., Kim S., Wilson C.J., Lehar J., Kryukov G.V., Sonkin D., Reddy A., Liu M., Murray L., Berger M.F., Monahan J.E., Morais P., Meltzer J., Korejwa A., Jane-Valbuena J., Mapa F.A., Thibault J., Bric-Furlong E., Raman P., Shipway A., Engels I.H., Cheng J., Yu G.K., Yu J., Aspesi P. Jr., de Silva M., Jagtap K., Jones M.D., Wang L., Hatton C., Palescandolo E., Gupta S., Mahan S., Sougnez C., Onofrio R.C., Liefeld T., MacConaill L., Winckler W., Reich M., Li N., Mesirov J.P., Gabriel S.B., Getz G., Ardlie K., Chan V., Myer V.E., Weber B.L., Porter J., Warmuth M., Finan P., Harris J.L., Meyerson M., Golub T.R., Morrissey M.P., Sellers W.R., Schlegel R., Garraway L.A.
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity.
Nature 483:603-607(2012)

PubMed=25485619; DOI=10.1038/nbt.3080
Klijn C., Durinck S., Stawiski E.W., Haverty P.M., Jiang Z., Liu H., Degenhardt J., Mayba O., Gnad F., Liu J., Pau G., Reeder J., Cao Y., Mukhyala K., Selvaraj S.K., Yu M., Zynda G.J., Brauer M.J., Wu T.D., Gentleman R.C., Manning G., Yauch R.L., Bourgon R., Stokoe D., Modrusan Z., Neve R.M., de Sauvage F.J., Settleman J., Seshagiri S., Zhang Z.
A comprehensive transcriptional portrait of human cancer cell lines.
Nat. Biotechnol. 33:306-312(2015)

PubMed=27397505; DOI=10.1016/j.cell.2016.06.017
Iorio F., Knijnenburg T.A., Vis D.J., Bignell G.R., Menden M.P., Schubert M., Aben N., Goncalves E., Barthorpe S., Lightfoot H., Cokelaer T., Greninger P., van Dyk E., Chang H., de Silva H., Heyn H., Deng X., Egan R.K., Liu Q., Mironenko T., Mitropoulos X., Richardson L., Wang J., Zhang T., Moran S., Sayols S., Soleimani M., Tamborero D., Lopez-Bigas N., Ross-Macdonald P., Esteller M., Gray N.S., Haber D.A., Stratton M.R., Benes C.H., Wessels L.F.A., Saez-Rodriguez J., McDermott U., Garnett M.J.
A landscape of pharmacogenomic interactions in cancer.
Cell 166:740-754(2016)

Cross-references
Cell line collections DSMZ; ACC-547
JCRB; JCRB0118
JCRB; NIHS0147 - Discontinued
Cell line databases/resources CCLE; SKM1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
Cosmic-CLP; 909722
GDSC; 909722
Ontologies EFO; EFO_0006753
Biological sample resources BioSample; SAMN03470798
BioSample; SAMN03473113
Chemistry resources ChEMBL-Cells; CHEMBL3308216
ChEMBL-Targets; CHEMBL2366085
Gene expression databases ArrayExpress; E-MTAB-2706
GEO; GSM482513
GEO; GSM887581
GEO; GSM888664
GEO; GSM1374880
GEO; GSM1446741
GEO; GSM1670435
Polymorphism and mutation databases Cosmic; 787477
Cosmic; 909722
Cosmic; 975300
Cosmic; 1012119
Cosmic; 1078731
Cosmic; 1465964
Cosmic; 1551462
Cosmic; 2131566